Silence Therapeutics reported $62.3M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
AstraZeneca USD 47.33B 1.33B Mar/2026
Autolus Therapeutics Ltd USD 108.83M 69.3M Mar/2026
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Novartis USD 38.93B 7.2B Mar/2026
Roche Holding CHF 33.8B 758M Dec/2025
Silence Therapeutics USD 62.3M 11.76M Dec/2025